Open Access
BIO Web Conf.
Volume 14, 2019
The 12th International Conference on the Health Effects of Incorporated Radionuclides (HEIR 2018)
Article Number 07005
Number of page(s) 3
Section Nuclear Medicine, Targeted Therapy and Medical Imaging: Poster presentation
Published online 07 May 2019
  • Stannard, C., et al., Radiotherapy for ocular tumours. Eye, 27(2): p. 119-127 (2013) [CrossRef] [Google Scholar]
  • Melia, B.M., et al., Collaborative ocular melanoma study (COMS)randomized trial of I-125 brachytherapy for medium choroidal melanoma.I. Visual acuity after 3 years COMS report no. 16. Ophthalmology,. 108(2):p.348-66 (2001) [CrossRef] [PubMed] [Google Scholar]
  • Wilkinson, D.A., et al., Dosimetric comparison of Ru-106 and I-125 plaquesfor treatment of shallow (<= 5 mm) choroidal melanoma lesions. BritishJournal of Radiology, 81(970): p. 784-789 (2008) [Google Scholar]
  • Zaragoza, F.J., et al., Monte Carlo Estimation of Absorbed DoseDistributions Obtained from Heterogeneous (106)Ru Eye Plaques. OculOncol Pathol, 3(3): p. 204-209 (2017) [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.